Appaloosa is one of the more popular funds within the hedge fund world. Its founder and manager, David Tepper, gained a level of celebrity status after receiving $3 billion in annual compensation for the firm’s 2013 performance. The firm invests in fixed income and distressed debt, and therefore its 13F filing covers only a fraction of its overall investing activity, though its equity book has often been a strong source of returns. Its AUM, as listed on its 13F, went up from $764 million to $9,065 million between Q4 2011 and Q1 2014, a factor of approximately 12x. Although its listed AUM (i.e., equity only) sits at just $7.1 billion, down 22% from its peak, it has increased in each of the past five quarters. Tepper’s style of investing is more active, with a lot of turnover quarter to quarter. Its top 10 holdings, though, account for a fairly moderate 57% of the portfolio. Notable tech names are present in the top 10, including MU (top holding), BABA, FB, GOOG, WDC, and AAPL. Allergan (AGN) was the fund’s top holding at 11.5% of the portfolio last quarter, though it has since been cut down to 5.4%. Like most generics makers, its share price has stagnated due to competition and litigation concerns. The firm’s 48 holdings (and 14 positions it sold out of last quarter) can be found below: (click to enlarge)